1.
Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, ph...
by Brose, Marcia S, Dr
The lancet oncology, 2016, Vol.17 (9), p.1272-1282
2.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
by Brose, Marcia S, Dr
The Lancet (British edition), 2014, Vol.384 (9940), p.319-328
Filter electronic articles 2 Hits
Remove Filters
- Tumors (2)
- Drug Dosages (2)
- Medical Prognosis
- Metastasis (2)
- Chemotherapy (1)
- Double (1)
- Diagnosis (1)
- Double-Blind Method (1)
- Blind Method (1)
- Drug Therapy (1)
- Aged, 80 And Over (1)
- Aged (1)
- Adult (1)
- Antineoplastic Agents (1)
- Antineoplastic Agents - Administ... (1)
- Antineoplastic Agents - Therapeu... (1)
- Biological And Medical Sciences (1)
- less ...